(Q51374433)

English

Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.

scientific article published in September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission. (English)

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

circulatory system

1 reference

based on heuristic

inferred from title

Cushing's syndrome

0 references

11

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

author name string

Roberta Giordano

1

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Andreea Picu

2

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Elisa Marinazzo

3

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Valentina D'Angelo

4

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Rita Berardelli

5

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Ioannis Karamouzis

6

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Daniela Forno

7

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Domenico Zinnà

8

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Mauro Maccario

9

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Ezio Ghigo

10

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

publication date

1 September 2011

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Clinical Endocrinology

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

75

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

3

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

354-360

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Diagnosis and complications of Cushing's syndrome: a consensus statement.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Morbidity and mortality in Cushing's disease: an epidemiological approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Incidence and late prognosis of cushing's syndrome: a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Glucocorticoids and insulin resistance: old hormones, new targets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Pathophysiology of dyslipidemia in Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Blood-pressure reduction and cardiovascular risk in HOPE study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Loss of body cell mass in Cushing's syndrome: effect of treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Adrenal incidentaloma: a new cause of the metabolic syndrome?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04055.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2011.04055.X

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

1 reference

Europe PubMed Central

4 April 2018

http://europepmc.org/abstract/MED/21521323

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51374433&oldid=1302072431"